Enhanced radiosensitivity of SW480 cells via TRAIL up-regulation mediated by Egr-1 promoter

Oncology Reports

Volumn 22, Issue 4, 2009, Pages 765-771

  Hu, Y ^a   Ouyang, W ^a   Wu, F ^a   Cao, C H ^a   Wang, K ^a   Liao, Z K ^a   Zhong, Y H ^a   Zhou, F X ^a   Liu, S Q ^a   Xia, L ^a   Zhou, Y F ^a   Xie, Cong Hua ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Apoptosis; Egr 1 promoter; Radio sensitivity; SW480 cells; TRAIL

Indexed keywords

ANTINEOPLASTIC AGENT; MESSENGER RNA; PLASMID DNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND EARLY TRANSCRIPTONAL FACTOR 1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER GENE THERAPY; CANCER RADIOTHERAPY; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; COLON CANCER; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIOSENSITIVITY; REGULATORY MECHANISM; UPREGULATION;

APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; COLONIC NEOPLASMS; EARLY GROWTH RESPONSE PROTEIN 1; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; HUMANS; PLASMIDS; PROMOTER REGIONS, GENETIC; RADIATION TOLERANCE; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSFECTION; UP-REGULATION;

EID: 70350349502     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000498     Document Type: Article

References (43)

1. Hingorani M, White CL, Agrawal VK, Vidal L, Melcher A and Harrington KJ: Combining radiation and cancer gene therapy: a potential marriage of physical and biological targeting? Curr Cancer Drug Targets 7: 389-409, 2007.
2. McBride WH, Chiang CS, Olson JL, Wang CC, Hong JH, Pajonk F, Dougherty GJ, Iwamoto KS, Pervan M and Liao YP: A sense of danger from radiation. Radiat Res 162: 1-19, 2004.
3. Borgmann K, Roper B, El-Awady R, Brackrock S, Bigalke M, Dork T, Alberti W, Dikomey E and Dahm-Daphi J: Indicators of late normal tissue response after radiotherapy for head and neck cancer: fibroblasts, lymphocytes, genetics, DNA repair, and chromosome aberrations. Radiother Oncol 64: 141-152, 2002.
4. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM and Bos JL: Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525-532, 1988.
5. Stevens CW, Zeng M and Cerniglia GJ: Ionizing radiation greatly improves gene transfer efficiency in mammalian cells. Hum Gene Ther 7: 1727-1734, 1996.
6. Zeng M, Cerniglia GJ, Eck SL and Stevens CW: High-efficiency stable gene transfer of adenovirus into mammalian cells using ionizing radiation. Hum Gene Ther 8: 1025-1032, 1997.
7. Hsu H, Rainov NG, Quinones A, Eling DJ, Sakamoto KM and Spear MA: Combined radiation and cytochrome CYP4B1/4-ipomeanol gene therapy using the EGR1 promoter. Anticancer Res 23: 2723-2728, 2003.
8. Zwiebel JA: Cancer gene and oncolytic virus therapy. Semin Oncol 28: 336-3343, 2001.
9. Wiley SR, Schooley K, Smolak PJ, et al: Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3: 673-682, 1995.
10. LeBlanc HN and Ashkenazi A: Apo2L/TRAIL and its death and decoy receptors. Cell Death Differ 10: 66-75, 2003.
11. Smyth MJ, Takeda K, Hayakawa Y, Peschon JJ, van den Brink MR and Yagita H: Nature's TRAIL - on a path to cancer immunotherapy. Immunity 18: 1-6, 2003.
12. Tsurushima H, Yuan X, Dillehay LE and Leong KW: Radio-responsive tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene therapy for malignant brain tumors. Cancer Gene Ther 14: 706-716, 2007.
13. Wu F, Hu Y, Long J, Zhou YJ, Zhong YH, Liao ZK, Liu SQ, Zhou FX, Zhou YF and Xie CH: Cytotoxicity and radio-sensitization effect of TRA-8 on radioresistant human larynx squamous carcinoma cells. Oncol Rep 21: 461-465, 2009.
14. Zhu H, Cao CH and Xie CH: The Property of Egr-1 promoter in irradiation-induced gene expression. Med J Wuhan Univ 29: 186-189, 2008.
15. Mathes SJ and Alexander J: Radiation injury. Surg Oncol Clin N Am 5: 809-824, 1996.
16. Swisher SG, Roth JA, Komaki R, Gu J, Lee JJ, Hicks M, Ro JY, Hong WK, Merritt JA, Ahrar K, Atkinson NE, Correa AM, Dolormente M, Dreiling L, El-Naggar AK, Fossella F, Francisco R, Glisson B, Grammer S, Herbst R, Huaringa A, Kemp B, Khuri FR, Kurie JM, Liao Z, McDonnell TJ, Morice R, Morello F, Munden R, Papadimitrakopoulou V, Pisters KM, Putnam JB Jr, Sarabia AJ, Shelton T, Stevens C, Shin DM, Smythe WR, Vaporciyan AA, Walsh GL and Yin M: Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy. Clin Cancer Res 9: 93-101, 2003.
17. Senzer N, Mani S, Rosemurgy A, Nemunaitis J, Cunningham C, Guha C, Bayol N, Gillen M, Chu K, Rasmussen C, Rasmussen H, Kufe D, Weichselbaum R and Hanna N: TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors. J Clin Oncol 22: 592-601, 2004.
18. Ashkenazi A and Dixit VM: Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 11: 255-260, 1999.
19. Strater J, Hinz U, Walczak H, Mechtersheimer G, Koretz K, Herfarth C, Moller P and Lehnert T: Expression of TRAIL and TRAIL receptors in colon carcinoma: TRAIL-R1 is an independent prognostic parameter. Clin Cancer Res 8: 3734-3740, 2002.
20. Voelkel-Johnson C, King DL and Norris JS: Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL. Cancer Gene Ther 9: 164-172, 2002.
21. Seol JY, Park KH, Hwang CI, Park WY, Yoo CG, Kim YW, Han SK, Shim YS and Lee CT: Adenovirus-TRAIL can overcome TRAIL resistance and induce a bystander effect. Cancer Gene Ther 10: 540-548, 2003.
22. Kagawa S, He C, Gu J, Koch P, Rha SJ, Roth JA, Curley SA, Stephens LC and Fang B: Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene. Cancer Res 61: 3330-3338, 2001.
23. Huang X, Lin T, Gu J, Zhang L, Roth JA, Liu J and Fang B: Cell to cell contact required for bystander effect of the TNF-related apoptosis-inducing ligand (TRAIL) gene. Int J Oncol 22: 1241-1245, 2003.
24. Jo M, Kim TH, Seol DW, Esplen JE, Dorko K, Billiar TR and Strom SC: Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand. Nat Med 6: 564-567, 2000.
25. Nitsch R, Bechmann I, Deisz RA, Haas D, Lehmann TN, Wendling U and Zipp F: Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL). Lancet 356: 827-828, 2000.
26. Datta R, Rubin E, Sukhatme V, Qureshi S, Hallahan D, Weichselbaum RR and Kufe DW: Ionizing radiation activates transcription of the EGR1 gene via CArG elements. Proc Natl Acad Sci USA 89: 10149-10153, 1992.
27. Chinnaiyan AM, Prasad U, Shankar S, Hamstra DA, Shanaiah M, Chenevert TL, Ross BD and Rehemtulla A: Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy. Proc Natl Acad Sci USA 97: 1754-1759, 2000.
28. Dai DJ, Xie CH, Zhang AL, Qiu HB and Zhou ZY: Experimental study on synergistic effect of TRAIL combined with radioactive ray on human U251 glioma cell lines. Med J Wuhan Univ 27: 759-762, 2006.
29. Gong B and Almasan A: Apo2 ligand/TNF-related apoptosisinducing ligand and death receptor 5 mediate the apoptotic signaling induced by ionizing radiation in leukemic cells. Cancer Res 60: 5754-5760, 2000.
30. Belka C, Jendrossek V, Pruschy M, Vink S, Verheij M and Budach W: Apoptosis-modulating agents in combination with radiotherapy-current status and outlook. Int J Radiat Oncol Biol Phys 58: 542-554, 2004.
31. Stennicke HR, Jurgensmeier JM, Shin H, Deveraux Q, Wolf BB, Yang X, Zhou Q, Ellerby HM, Ellerby LM, Bredesen D, Green DR, Reed JC, Froelich CJ and Salvesen GS: Pro-caspase-3 is a major physiologic target of caspase-8. J Biol Chem 273: 27084-27090, 1998.
32. Luo X, Budihardjo I, Zou H, Slaughter C and Wang X: Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94: 481-490, 1998.
33. Ferreira CG, Epping M, Kruyt FA and Giaccone G: Apoptosis: target of cancer therapy. Clin Cancer Res 8: 2024-2034, 2002.
34. Nakano K and Vousden KH: PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7: 683-694, 2001.
35. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB and Korsmeyer SJ: Proapoptotic BAX and BAK: a requisite gate-way to mitochondrial dysfunction and death. Science 292: 727-730, 2001.
36. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES and Wang X: Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479-489, 1997.
37. Haimovitz-Friedman A, Kan CC, Ehleiter D, Persaud RS, McLoughlin M, Fuks Z and Kolesnick RN: Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med 180: 525-535, 1994.
38. Mitsiades N, Poulaki V, Mitsiades C and Tsokos M: Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5. Cancer Res 61: 2704-2712, 2001.
39. Kuang AA, Diehl GE, Zhang J and Winoto A: FADD is required for DR4- and DR5-mediated apoptosis: lack of trail-induced apoptosis in FADD-deficient mouse embryonic fibroblasts. J Biol Chem 275: 25065-25068, 2000.
40. Srivastava RK, Chen Q, Siddiqui I, Sarva K and Shankar S: Linkage of curcumin-induced cell cycle arrest and apoptosis by cyclin-dependent kinase inhibitor p21(/WAF1/CIP1). Cell Cycle 6: 2953-2961, 2007.
41. Shi MD, Lin HH, Lee YC, Chao JK, Lin RA and Chen JH: Inhibition of cell-cycle progression in human colorectal carcinoma Lovo cells by andrographolide. Chem Biol Interact 174: 201-210, 2008.
42. Teyssier F, Bay JO, Dionet C and Verrelle P: Cell cycle regulation after exposure to ionizing radiation. Bull Cancer 86: 345-357, 1999.
43. Hunakova L, Chorvath M, Duraj J, Bartosova Z, Sevcikova L, Sulikova M, Chovancova J, Sedlak J, Chorvath B and Boljesikova E: Radiation-induced apoptosis and cell cycle alterations in human carcinoma cell lines with different radio-sensitivities. Neoplasma 47: 25-31, 2000.